Plus Therapeutics Inc - Company Profile
Powered by
All the data and insights you need on Plus Therapeutics Inc in one report.
- Save hours of research time and resources with
our up-to-date Plus Therapeutics Inc Strategy Report
- Understand Plus Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
The following section provides information on Plus Therapeutics Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Plus Therapeutics Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Richard J. Hawkins
Chairman Executive BoardMr. Richard J. Hawkins has been the Chairman of the company since 2018. He joined Cytori Therapeutics as a Director in 2007. He is also the Chief Executive Officer of Lumos Pharma, Inc. Earlier, he founded LabNow Inc and served as the Chief Executive Officer (CEO) and Chairman of the company from 2004 to 2009. Mr. Hawkins founded Pharmaco, a clinical drug development services company and served as the CEO, Chairman and President. He is also the founder of id2, Concave Biotechnology and Sensus Drug Development Corp. Previously, he served as the Chairman of LoopOne Inc.
Marc H. Hedrick, M.D.
Chief Executive Officer; Director; President Executive BoardDr. Marc H. Hedrick has been the President, the Chief Executive Officer and a Director of the company since 2014. He joined Cytori as the Chief Scientific Officer and Medical Director in October 2002. Previously, Mr. Hedrick co-founded, and served as the President and Chief Executive Officer of StemSource, Inc. He is also a plastic surgeon and a former Associate Professor of Surgery and Pediatrics at the University of California, Los Angeles (UCLA). From 1998 to 2005, Dr. Hedrick directed the Laboratory of Regenerative Bioengineering and Repair for the Department of Surgery at UCLA.
Andrew Sims
Chief Financial Officer; Vice President Senior ManagementMr Andrew J. Sims has been the Chief Financial Officer and Vice President of the company since 2020. Prior to this, he served as the Chief Financial Officer at various private equity firms. He also served as partner at Mazars, a global accounting, advisory, audit, tax and consulting firm.
Norman LaFrance
Senior Vice President; Chief Medical Officer Senior ManagementMr. Norman LaFrance has been the Chief Medical Officer and the Senior Vice President of the company since 2021. Previously, he served as the Chief Medical Officer and Senior Vice President of Jubiliant Pharma Ltd from 2012 to 2022.
Russ Havranek
Vice President - Corporate Strategy and New Product Planning Senior ManagementHave you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer